Healthcare -
Biotechnology - NASDAQ - US
$ 1.277
-5.41 %
$ 148 M
Market Cap
-14.19
P/E
CHRS - OTHER LONG-TERM ASSETS
Other Long-term Assets CHRS - Coherus BioSciences, Inc.
71.3 M
LAST VALUE
43.75%
2 YEAR CAGR
33.37%
5 YEAR CAGR
119.86%
10 YEAR CAGR